期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Diffuse large B-Cell lymphoma:from novel molecular classifications to tailored targeted therapies
1
作者 jennifer k.lue Grzegorz S.Nowakowski 《Journal of Cancer Metastasis and Treatment》 2022年第1期501-525,共25页
Diffuse large B-cell lymphoma(DLBCL)is a heterogeneous disease comprising multiple genetic subtypes that translates and impacts clinical outcomes after standard chemoimmunotherapy.Our initial understanding of the comp... Diffuse large B-cell lymphoma(DLBCL)is a heterogeneous disease comprising multiple genetic subtypes that translates and impacts clinical outcomes after standard chemoimmunotherapy.Our initial understanding of the complex biological subtypes of DLBCL began with the identification of cell of origin(COO),and now has evolved to include even more specific subtypes defined by genetic signatures and mutations.These newer classifications lend themselves to the application of precision-based medicine,allowing us to tailor new treatment platforms that target specific oncogenic drivers in order to improve DLBCL outcomes.Essential to this is the development of genetic assays and tools that are reliable and readily available to assist in the application of these molecular classifications to real-world use.In this review,we discuss the history of DLBCL classification systems and their implication on clinical investigation as well as novel therapeutic options in DLBCL. 展开更多
关键词 DLBCL tumor heterogeneity activated-B-cell germinal center molecular targets
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部